Bharat Electronics Q1 FY27 (consolidated, ₹ crore)
| Metric | Value |
|---|---|
| Revenue | 5,716.54 |
| Revenue YoY growth | 24.19% |
| EBITDA | 1,388.40 |
| EBITDA margin | 24.29% |
| Net profit | 1,054.53 |
| Net profit YoY growth | 8.82% |
Here's the thing about Bharat Electronics.
That's a massive number, roughly 12 times its annual revenue. But here's what most people miss: this money doesn't turn into sales overnight. Transcript
The conversion cycle depends entirely on what you're building. Smaller base orders typically take 12 to 18 months to deliver. These are the ones that will drive revenue in FY27 and FY28. Large platform orders are a different beast altogether. They take about two years just to start producing significant turnover, and the execution of a major order itself takes around two years. Transcript +1
Think about it this way: the ₹72,258 crore order book includes massive projects like Fuzes, LRSAM (long-range surface-to-air missile), LCA Mk1/Mk1A LRUs (line replaceable units), the BMP-2 upgrade, Ashwini Radar, the EW suite for Mi-17 V5, and MPR Arudhra. These top seven or eight projects alone account for about ₹20,000 crore. The rest comes from hundreds of smaller line items. Transcript
Now, let's talk about those three orders everyone's excited about. Between August 26 and October 13, 2026, BEL announced orders worth ₹730 crore, ₹648 crore, and ₹533 crore. That's roughly ₹1,911 crore in total. Other +2
Here's the reality check: Q1 FY27 covers April to June 2026. These orders were announced in August, September, and October. They couldn't have possibly caused the Q1 revenue surge. The Q1 revenue came from executing the existing order book, not from these new announcements. Other +2
Even looking forward, these orders are relatively small. Together, they total about 2.6% of the order book. They cover communication equipment, avionics, cybersecurity solutions, drones, jammers, and other products. But given the 12-18 month delivery cycle for smaller orders, they'll mostly feed FY27-28 revenue, not immediately. Other +2
This is where things get interesting. Revenue grew about 25% year-on-year to ₹5,546.98 crore (company filing basis) or ₹5,716.54 crore (consolidated). But net profit grew only about 9% to ₹1,054.53 crore. Transcript
The culprit? Cost of materials. It surged 55.7% year-on-year to ₹3,035.88 crore, according to market reports. That's significantly higher than the revenue growth rate. But here's what management said: the margin decline was due to product mix variation, not input cost pressure. Transcript +1
It drifts by 3-4 points depending on product mix, which he called normal. He said there was no pressure from raw material costs. Transcript +1
So what's happening? Q1 margins reflected a mix of about 10 major projects, including LRSAM, MPR Arudhra, Lynx U2, and EON-51. Margins vary by solution type within each service, not by service. When you're executing more lower-margin projects in a quarter, your overall margin takes a hit even if revenue is growing. Transcript +1
Some analysts pointed to a 58% sequential decline in cost of materials from Q4 FY26 to Q1 FY27 as evidence of supply chain efficiency. But here's the simpler explanation: seasonality. Q4 FY26 revenue was ₹10,334.65 crore against ₹5,716.54 crore in Q1 FY27. When volumes drop that sharply, material consumption drops too. Transcript
The company doesn't expect capacity limits to constrain execution over the coming years. Large projects are underway at Palasamudram, Chitrakoot, and Vellore to support diversified products and new product lines. Transcript +1
In July 2026, BEL's board approved increasing authorised share capital from ₹750 crore to ₹1,000 crore. Shareholders gave it the green light in August with 99.75% voting in favor. Other +1
This creates 250 crore new equity shares, increasing headroom by about ₹269 crore above the current paid-up capital of about ₹731 crore. The company says this gives flexibility to meet future capital requirements, including issuing further equity shares if necessary. Other +1
But here's the key point: there's no linked bonus, rights issue, or fundraise announced. The last bonus was in FY2022-23. This is purely an enabling provision. Other +1
Can BEL fund its plans internally? The FY26 balance sheet shows cash and bank balances of ₹1,887.96 crore, zero debt, and operating cash flow of ₹1,541.37 crore. Capex was ₹985.36 crore. For FY27, management guided capex of more than ₹1,200 crore and R&D spend of more than ₹2,200 crore. Transcript +1
On paper, internal accruals and the existing cash balance cover the guided capex. Neither dilution nor debt looks necessary for capex right now. The working capital swings from large defence projects are the main uncertainty.
Here's the puzzle. BEL's stock has declined 14% over six months and 4% year-to-date, even as it accumulates orders and reports decent revenue growth. The stock hit a 52-week low of ₹360.80 on October 9, 2026, and trades around ₹382. Transcript
Why? Let's look at what happened after Q1 results. The shares fell more than 3% because earnings missed expectations. Revenue grew 25%, but profit grew only 9% due to higher input costs. The EBITDA margin was 24.3%, against 26.9% a year earlier and a 28% full-year guidance. Transcript
The market is pricing in doubt about margin recovery.
When you pay that kind of multiple, you expect consistent margin expansion, not compression. Transcript
The recent August-October orders total about ₹1,900 crore. That's nice, but it's not what moves the needle for a company with a ₹72,000 crore order book. Other +2
The real game-changer is QRSAM (quick reaction surface-to-air missile).
But QRSAM has faced procedural delays, and Q1 inflow was lean. Transcript +3
The stock is essentially waiting for two things: confirmation that large orders like QRSAM will come through, and evidence that margins can recover toward the 28% guidance. Until then, the market remains skeptical despite the headline order book numbers.
BEL's fundamentals remain strong. Zero debt, solid cash generation, a massive order book, and consistent revenue growth. But the stock has gotten ahead of itself, trading at premium valuations that assume flawless execution and margin expansion.
The recent orders add to the long-term story but don't change the near-term narrative. The divergence between fundamental performance and stock price reflects the market's impatience with margin pressure and uncertainty around large order timelines. For investors, the question isn't whether BEL has orders—it's whether it can convert them into profits at the margins the market expects.
